CIK 0001829635 · <br>Emerging growth company
Transcode Therapeutics, Inc.
Sign in to watch- Ticker
- RNAZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811065054
- Phone
- 857-301-6857
- Business address
- 6 LIBERTY SQUARE, #2382, BOSTON, MA, 02109
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-10 | Manting Erik Director | Grant or award · Stock Option (Right to Buy) | +9,500 | 9,500 | ||
| 2023-05-10 | Marquet Magda Director | Grant or award · Stock Option (Right to Buy) | +9,500 | 9,500 | ||
| 2023-05-10 | Calais Philippe Director | Grant or award · Stock Option (Right to Buy) | +9,500 | 9,500 | ||
| 2022-12-12 | Fitzgerald Thomas A Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2022-12-12 | Dudley Robert Michael Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +135,000 | 135,000 | ||
| 2022-12-12 | Medarova Zdravka Chief Technology Officer | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2022-09-14 | Dudley Robert Michael Chief Executive Officer | Purchase | +20,000 | $1.15 | $23K | 893,114 |
| 2022-06-22 | Calais Philippe Director | Grant or award · Stock Option (Right to Buy) | +9,500 | 9,500 | ||
| 2022-06-22 | Marquet Magda Director | Grant or award · Stock Option (Right to Buy) | +9,500 | 9,500 | ||
| 2022-06-22 | Manting Erik Director | Grant or award · Stock Option (Right to Buy) | +9,500 | 9,500 | ||
| 2022-06-16 | Fitzgerald Thomas A Chief Financial Officer | Purchase | +12,000 | $1.27 | $15K | 139,377 |
| 2022-05-31 | Dudley Robert Michael Chief Executive Officer | Purchase | +2,000 | $1.87 | $4K | 873,114 |
| 2022-05-27 | Dudley Robert Michael Chief Executive Officer | Purchase | +28,000 | $1.84 | $52K | 871,114 |
| 2022-03-01 | Fitzgerald Thomas A Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +52,000 | 52,000 | ||
| 2022-02-01 | Medarova Zdravka Chief Technology Officer | Grant or award · Stock Option (Right to Buy) | +33,000 | 33,000 | ||
| 2022-02-01 | Fitzgerald Thomas A Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +33,000 | 33,000 | ||
| 2022-02-01 | Dudley Robert Michael Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +135,000 | 135,000 |
Page 2 of 2 · 37 trades